Cancer biology: Enzyme meets a surprise target.
Helen Diller Family Comprehensive Cancer Center and the Department of Cell and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, USA.
Marian M
MM
Deuker
Helen Diller Family Comprehensive Cancer Center and the Department of Cell and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94158, USA.
Martin
M
McMahon
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000378:metabolism*; D011495:Histone-Lysine N-Methyltransferase / Q000378:metabolism*; D006801:Humans; D008239:Lysine / Q000378:metabolism*; D048730:MAP Kinase Kinase Kinase 2 / Q000378:metabolism*; D020930:MAP Kinase Kinase Kinases / Q000378:metabolism*; D015689:Oncogene Protein p21(ras) / Q000378:metabolism*
D011495:Histone-Lysine N-Methyltransferase; C506278:SMYD3 protein, human; C582787:Smyd3 protein, mouse; D048730:MAP Kinase Kinase Kinase 2; D020930:MAP Kinase Kinase Kinases; C482618:MAP3K2 protein, human; C482619:Map3k2 protein, mouse; D015689:Oncogene Protein p21(ras); D008239:Lysine